Mumbai, India

Venkatasubramaniam Radhakrishnan Tarur


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Venkatasubramaniam Radhakrishnan Tarur

Introduction

Venkatasubramaniam Radhakrishnan Tarur, based in Mumbai, India, is a notable inventor recognized for his significant contribution to the field of pharmaceuticals. With a focus on developing processes that aid in medical applications, he has successfully patented a vital compound that plays a crucial role in ocular health.

Latest Patents

Venkatasubramaniam holds a patent for the "Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S)methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl." This invention pertains to an improved method for synthesizing Dorzolamide Hydrochloride, which is instrumental in reducing intraocular pressure by inhibiting the carbonic anhydrase enzyme.

Career Highlights

Currently working at the Council of Scientific & Industrial Research, Venkatasubramaniam has dedicated his career to advancing pharmaceutical research. His work has enhanced the development of therapeutic agents critical for managing various eye conditions.

Collaborations

In his research endeavors, Venkatasubramaniam has collaborated with esteemed colleagues such as Mukund Keshao Gurjar and Madhusudan Nagorao Deshmukh. Together, they have contributed to innovative solutions within the scientific community, promoting advancements in medicinal chemistry.

Conclusion

Venkatasubramaniam Radhakrishnan Tarur's innovative work exemplifies the essential role of inventors in the realm of healthcare and pharmaceuticals. His patent not only showcases his ingenuity but also holds promise for the betterment of patients suffering from intraocular pressure issues. As he continues his work at the Council of Scientific & Industrial Research, more breakthroughs in science and medicine are anticipated from his research initiatives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…